Pediatric Endocrinology Diabetes and Metabolism
en ENGLISH
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
Wyszukiwanie
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

without publication fees

Zintegrowane z publons

integrated with publons
4/2025
vol. 31
 
Poleć ten artykuł:
Wyślij znajomemu
Udostępnij:
Artykuł przeglądowy

Czynniki środowiskowe w rozwoju cukrzycy typu 1 u dzieci: protokół systematycznego przeglądu i metaanalizy dotyczącej wpływu zakażenia i szczepienia przeciw COVID-19

Olga Kamińska-Jackowiak
1, 2
,
Martyna Kolasa
1, 2
,
Agata Chobot
1, 2
,
Tiago Jeronimo dos Santos
3

  1. Department of Pediatrics, Institute of Medical Sciences, University of Opole, Poland
  2. Department of Pediatrics, University Clinical Hospital in Opole, Poland
  3. Department of Nursing Sciences, Physiotherapy, and Medicine, Faculty of Health Sciences, University of Almería, Spain
Pediatr Endocrinol Diabetes Metab 2025; 31 (4): 204-208
DOI: https://doi.org/10.5114/pedm.2025.158543
Data publikacji online: 2026/01/27
Plik artykułu:
- 0422_Environmental triggers.pdf  [0.80 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Libman I, Haynes A, Lyons S, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 2022; 23: 1160–1174. doi: 10.1111/PEDI.13454.
2. Richardson SJ, Morgan NG. Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention. Curr Opin Pharmacol 2018; 43: 11–19. doi: 10.1016/J.COPH.2018.07.006.
3. Lönnrot M, Lynch KF, Elding Larsson H, et al. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study. Diabetologia 2017; 60: 1931–1940. doi: 10.1007/S00125-017-4365-5.
4. Ruiz PLD, Tapia G, Bakken IJ, et al. Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study. Diabetologia 2018; 61: 1996–2004. doi: 10.1007/S00125-018-4662-7/FIGURES/4.
5. Rahmati M, Yon DK, Lee SW, et al. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies. J Med Virol 2023; 95: e28833. doi: 10.1002/JMV.28833.
6. D’Souza D, Empringham J, Pechlivanoglou P, et al. Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. JAMA Netw Open 2023; 6: E2321281. doi: 10.1001/JAMANETWORKOPEN.2023.21281.
7. Hormazábal-Aguayo I, Ezzatvar Y, Huerta-Uribe N, et al. Incidence of type 1 diabetes mellitus in children and adolescents under 20 years of age across 55 countries from 2000 to 2022: A systematic review with meta-analysis. Diabetes Metab Res Rev 2024; 40. doi: 10.1002/DMRR.3749.
8. Ortqvist Å, Blennow M, Carlsson RM, et al. Vaccination of children – a systematic review. Acta Paediatr 2010; 99: 1–192. doi: 10.1111/j.1651-2227.2010.01823.x.
9. Fernández-Ramos C, Arana-Arri E, Vela A, et al. Increased incidence of pediatric type 1 diabetes during the pandemic in Biscay, Spain. Endocrinol Diabetes Nutr (Engl Ed) 2024; 71: 332–339. doi: 10.1016/j.endien.2024.09.002.
10. Pietrzak I, Michalak A, Seget S, et al. Diabetic ketoacidosis incidence among children with new-onset type 1 diabetes in Poland and its association with COVID-19 outbreak – Two-year cross-sectional national observation by PolPeDiab Study Group. Pediatr Diabetes 2022; 23: 10.1111/pedi.13379. doi: 10.1111/PEDI.13379.
11. Unsworth R, Wallace S, Oliver NS, et al. New-onset type 1 diabetes in children during COVID-19: Multicenter regional findings in the U.K. Diabetes Care 2020; 43: e170–e171. doi: 10.2337/DC20-1551.
12. Bering L, Christensen AV, Birk NM, et al. Risk of New-onset Type 1 Diabetes in Danish Children and Adolescents After SARS-CoV-2 Infection: A Nationwide, Matched Cohort Study. Pediatr Infect Dis J 2023; 42: 999–1001. doi: 10.1097/INF.0000000000004063.
13. Kamrath C, Eckert AJ, Holl RW, Rosenbauer J. Impact of the COVID-19 Pandemic on Children and Adolescents with New-Onset Type 1 Diabetes. Pediatr Diabetes 2023; 2023: 7660985. doi: 10.1155/2023/7660985.
14. Noorzae R, Junker TG, Hviid AP, et al. Risk of Type 1 Diabetes in Children Is Not Increased After SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark. Diabetes Care 2023; 46:1261–1264. doi: 10.2337/DC22-2351.
15. Pezzaioli LC, Gatta E, Bambini F, et al. Endocrine system after 2 years of COVID-19 vaccines: A narrative review of the literature. Front Endocrinol (Lausanne) 2022; 13. doi: 10.3389/FENDO.2022.1027047.
16. Lamichhane P, Khalid H, Siviyachan CK, et al. Immediate impacts of COVID-19 vaccination on glycemic control in type 1 diabetes mellitus: a systematic review and meta-analysis. Ann Med Surg (Lond) 2024; 86: 1613–1621. doi: 10.1097/MS9.0000000000001752.
17. Alsudais AS, Alkanani RS, Fathi AB, et al. Autoimmune diabetes mellitus after COVID-19 vaccination in adult population: a systematic review of case reports. BMC Endocr Disord. 2023; 23: 164. doi: 10.1186/S12902-023-01424-0.
18. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021; 372: n71. doi: 10.1136/BMJ.N71.
19. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016; 5: 210. doi: 10.1186/S13643-016-0384-4/FIGURES/6.
20. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603–605. doi: 10.1007/S10654-010-9491-Z.
21. Mameli C, Valsecchi C, Cereda D, et al. Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy. PLoS One 2025; 20: e0316340. doi: 10.1371/JOURNAL.PONE.0316340.
22. Xu ZR, Xi L, Wu J, et al. COVID-19 infection and inactivated vaccination: Impacts on clinical and immunological profiles in Chinese children with type 1 diabetes. World J Diabetes 2024; 15: 2276–2284. doi: 10.4239/WJD.V15.I12.2276.
23. Nóvoa-Medina Y, Pavlovic-Nesic S, González-Martín JM, et al. Role of the SARS-CoV-2 virus in the appearance of new onset type 1 diabetes mellitus in children in Gran Canaria, Spain. J Pediatr Endocrinol Metab 2022; 35: 393–397. doi: 10.1515/JPEM-2021-0727.
24. Noorzae R, Junker TG, Hviid AP, Wohlfahrt J, Olsen SF. Risk of Type 1 Diabetes in Children Is Not Increased After SARS-CoV-2 Infection: A Nationwide Prospective Study in Denmark. Diabetes Care 2023; 46: 1261–1264. doi: 10.2337/DC22-2351.
25. Reschke F, Lanzinger S, Herczeg V, et al. The COVID-19 Pandemic Affects Seasonality, With Increasing Cases of New-Onset Type 1 Diabetes in Children, From the Worldwide SWEET Registry. Diabetes Care 2022; 45: 2594–2601. doi: 10.2337/DC22-0278.

Termedia
O Wydawnictwie Oferty Newsletter Kontakt Praca
Polityka prywatności Polityka reklamowa Napisz do nas Nota prawna Regulamin
Na skróty
Aktualności Czasopisma Książki eBooki Konferencje i webinary Podcasty Mednauka
Serwisy
KONGRES TOP MEDICAL TRENDS Menedżer Zdrowia Lekarz POZ Choroby rzadkie Dermatologia Diabetologia Onkologia Neurologia Reumatologia Gastroenterologia Pulmonologia Ginekologia Kurier Medyczny Zalecenia i rekomendacje e-Praktyka Leczenia Ran Warto wiedzieć
e-Akademia
e-Akademia Zaburzeń Mikrobioty e-Akademia POChP e-Akademia Chorób Naczyń Akademia GLP-1
© 2026 Termedia Sp. z o.o.
Developed by Bentus.